Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03709446
Title Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Charles L Shapiro MD
Indications

triple-receptor negative breast cancer

Therapies

Leflunomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.